Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Internal and external traditional Chinese medicine treatment for gastrointestinal dysfunction in sepsis
ChiCTR2300071405Phase 2Not yet recruiting
- Sponsor
- Xiyuan Hospital
- Start
- May 2023
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Weichang Fuyuan Fang in sepsis (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Gastrointestinal dysfunction score (2016 revised Lushan conference standard) at Day 7. Planned start May 2023; status: not yet recruiting.
02
Drugs
Weichang Fuyuan Fang
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2300071405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071405.